JP2001139552A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001139552A5 JP2001139552A5 JP1999321175A JP32117599A JP2001139552A5 JP 2001139552 A5 JP2001139552 A5 JP 2001139552A5 JP 1999321175 A JP1999321175 A JP 1999321175A JP 32117599 A JP32117599 A JP 32117599A JP 2001139552 A5 JP2001139552 A5 JP 2001139552A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- fragment
- compound
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 17
- 239000000427 antigen Substances 0.000 description 15
- 102000036639 antigens Human genes 0.000 description 15
- 108091007433 antigens Proteins 0.000 description 15
- 239000012634 fragment Substances 0.000 description 12
- WCXDHFDTOYPNIE-RIYZIHGNSA-N (E)-acetamiprid Chemical compound N#C/N=C(\C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-RIYZIHGNSA-N 0.000 description 7
- 239000005875 Acetamiprid Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- -1 chloronicotinyl Chemical group 0.000 description 4
- 210000004408 hybridoma Anatomy 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000002917 insecticide Substances 0.000 description 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000000984 immunochemical effect Effects 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- CFRPSFYHXJZSBI-DHZHZOJOSA-N (E)-nitenpyram Chemical compound [O-][N+](=O)/C=C(\NC)N(CC)CC1=CC=C(Cl)N=C1 CFRPSFYHXJZSBI-DHZHZOJOSA-N 0.000 description 1
- 108010009685 Cholinergic Receptors Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 1
- 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 1
- WCXDHFDTOYPNIE-UHFFFAOYSA-N acetamiprid Chemical compound N#CN=C(C)N(C)CC1=CC=C(Cl)N=C1 WCXDHFDTOYPNIE-UHFFFAOYSA-N 0.000 description 1
- 102000034337 acetylcholine receptors Human genes 0.000 description 1
- 150000001409 amidines Chemical group 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229940079888 nitenpyram Drugs 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 230000001242 postsynaptic effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32117599A JP3940245B2 (ja) | 1999-11-11 | 1999-11-11 | アセタミプリドのハプテン化合物、抗体及び測定方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32117599A JP3940245B2 (ja) | 1999-11-11 | 1999-11-11 | アセタミプリドのハプテン化合物、抗体及び測定方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001139552A JP2001139552A (ja) | 2001-05-22 |
| JP2001139552A5 true JP2001139552A5 (enExample) | 2005-11-24 |
| JP3940245B2 JP3940245B2 (ja) | 2007-07-04 |
Family
ID=18129640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP32117599A Expired - Lifetime JP3940245B2 (ja) | 1999-11-11 | 1999-11-11 | アセタミプリドのハプテン化合物、抗体及び測定方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3940245B2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006282547A (ja) * | 2005-03-31 | 2006-10-19 | Horiba Ltd | ニテンピラムのハプテン化合物、抗体、ハイブリドーマ、およびその測定手段、測定用キットまたは測定方法 |
| JP4916128B2 (ja) * | 2005-05-20 | 2012-04-11 | 株式会社堀場製作所 | フィプロニルのハプテン化合物、抗体、ハイブリドーマおよびその測定手段、測定キットまたは測定方法 |
| CN105806970A (zh) * | 2014-12-31 | 2016-07-27 | 张海燕 | 一种定虫脒残留量的检测方法 |
| JP6473662B2 (ja) * | 2015-05-29 | 2019-02-20 | 公益財団法人科学技術交流財団 | イムノアッセイ法を用いた残留農薬検査のための前処理方法、及び残留農薬検査方法 |
| CN105754955B (zh) * | 2016-05-17 | 2019-02-15 | 江南大学 | 一株噻虫啉、啶虫脒单克隆抗体杂交瘤细胞株gw及其应用 |
| CN109111394B (zh) * | 2018-09-21 | 2021-09-03 | 中国烟草总公司郑州烟草研究院 | 一种啶虫脒半抗原与抗原的制备方法及应用 |
| CN111533744B (zh) * | 2020-05-14 | 2022-10-04 | 德州学院 | 一种非病毒载体、制备方法及其应用 |
| CN113943248B (zh) * | 2021-12-21 | 2022-03-08 | 信达安检测技术(天津)有限公司 | 一种啶虫脒半抗原、完全抗原及其合成与应用 |
-
1999
- 1999-11-11 JP JP32117599A patent/JP3940245B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69520383T2 (de) | Quaternäre ammonium immunogenische Konjugate und Immuntest-Reagenz | |
| DE3887675T2 (de) | Antikörper. | |
| EP0260610B1 (de) | Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung | |
| DE3177290T2 (de) | Monoklonale antikoerper gegen hepatitis-b-virus. | |
| JP2001139552A5 (enExample) | ||
| DE18795T1 (de) | Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen. | |
| KR900009096A (ko) | 이(2)특이적 단클론성 항체, 그의 제조방법 및 용도 | |
| EP0173648A2 (en) | New monoclonal antibodies to glycoconjugates, processes for their production, and applications | |
| DE2507901A1 (de) | Pharmazeutisches praeparat zur krebsbehandlung und verfahren zu dessen herstellung | |
| JP2025102964A (ja) | 分子トラップを使用して、アッセイからビオチン干渉を取り除く方法および組成物 | |
| JP7550187B2 (ja) | 共役分子トラップを使用して、アッセイからビオチン干渉を取り除く方法および組成物 | |
| Lombardi et al. | Assimilation of LDL by experimental tumours in mice | |
| CN106928166B (zh) | 一种呋虫胺半抗原、完全抗原和抗体及其制备方法与应用 | |
| Schumaker et al. | The free energy of angular position of the Fab arms of IgG antibody | |
| CA2059060C (en) | Cell surface receptor complimentation | |
| JP3940245B2 (ja) | アセタミプリドのハプテン化合物、抗体及び測定方法 | |
| JP3745411B2 (ja) | モノクローナル抗体 | |
| DE3885975T2 (de) | Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung. | |
| DE3114362A1 (de) | Verfahren zur herstellung von antikoerpern und von zu ihrer erzeugung geeigneten staemmen sowie verfahren zur immunopruefung mit hilfe derartiger antikoerper | |
| CN114317452B (zh) | 萘乙酸单克隆抗体、杂交瘤细胞株及应用 | |
| DE68904336T2 (de) | Anti-humankrebsproteinkomplexe, deren herstellung und verwendung. | |
| CN115340986A (zh) | 一株分泌甲拌磷单克隆抗体的杂交瘤细胞株及其应用 | |
| CN106929477B (zh) | 一株抗前列腺素F2α的特异性单克隆抗体杂交瘤细胞株WXX-2及其应用 | |
| DE3888924T2 (de) | Monoklonale Antikörper gegen Anthracycline. | |
| CN113717948A (zh) | 一株分泌抗菌核净单克隆抗体的杂交瘤细胞株及其应用 |